UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lintuzumab-225Ac in Combination with Venetoclax in Relapsed/Refractory AML: Early Results of a Phase I/II Study

Blood, 2020-11, Vol.136 (Supplement 1), p.24-25

2020

Volltextzugriff (PDF)

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

Supportive care in cancer, 2008-05, Vol.16 (5), p.477-483

2008

Volltextzugriff (PDF)

Latent transforming growth factor-β: Structural features and mechanisms of activation

Kidney international, 1997-05, Vol.51 (5), p.1376-1382

1997

Volltextzugriff (PDF)

Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1

Molecular biology of the cell, 1998-09, Vol.9 (9), p.2627-2638

1998

Volltextzugriff (PDF)

TGF‐β Latency: Biological Significance and Mechanisms of Activation

Stem cells (Dayton, Ohio), 1997-01, Vol.15 (3), p.190-197

1997

Volltextzugriff (PDF)

Tamoxifen and Estrogen Effects on TGF-β Formation: Role of Thrombospondin-1, αvβ3, and Integrin-Associated Protein

Biochemical and biophysical research communications, 2001-06, Vol.284 (1), p.11-14

2001

Volltextzugriff (PDF)

Bortezomib Added to the Standard Mobilization Regimen of G-CSF and High-Dose Cyclophosphamide Is a Safe and Effective Combination for a High Yield Stem Cell Collection While Promoting Further Tumor Mass Reduction in Myeloma

Blood, 2006-11, Vol.108 (11), p.2953-2953

2006

Volltextzugriff (PDF)

TGF-beta: structure, function, and formation

Thrombosis and haemostasis, 1993-07, Vol.70 (1), p.177-179

1993

Volltextzugriff (PDF)

Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

Blood, 1989-10, Vol.74 (5), p.1635-1643

1989

Volltextzugriff (PDF)

Control of transforming growth factor-β activity: Latency vs. activation

Progress in growth factor research, 1992, Vol.4 (4), p.321-335

1992

Volltextzugriff (PDF)

Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation

Journal of the American College of Cardiology, 1998-12, Vol.32 (7), p.2035-2042

1998

Volltextzugriff (PDF)

Thiolate ligation of the active site iron(II) of isopenicillin N synthase derives from substrate rather than endogenous cysteine: spectroscopic studies of site-specific Cys .fwdarw. Ser mutated enzymes

Biochemistry (Easton), 1992-05, Vol.31 (19), p.4602-4612

1992

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Lintuzumab-225Ac in Combination with Venetoclax in Relapsed/Refractory AML: Early Results of a Phase I/II Study

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

Latent transforming growth factor-β: Structural features and mechanisms of activation

Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1

TGF‐β Latency: Biological Significance and Mechanisms of Activation

Tamoxifen and Estrogen Effects on TGF-β Formation: Role of Thrombospondin-1, αvβ3, and Integrin-Associated Protein

Bortezomib Added to the Standard Mobilization Regimen of G-CSF and High-Dose Cyclophosphamide Is a Safe and Effective Combination for a High Yield Stem Cell Collection While Promoting Further Tumor Mass Reduction in Myeloma

TGF-beta: structure, function, and formation

Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

Control of transforming growth factor-β activity: Latency vs. activation

Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation

Thiolate ligation of the active site iron(II) of isopenicillin N synthase derives from substrate rather than endogenous cysteine: spectroscopic studies of site-specific Cys .fwdarw. Ser mutated enzymes

Suchergebnisse filtern